<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li Y</submitter><funding>Intramural NIH HHS</funding><pagination>2072-81</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4250366</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>28(12)</volume><pubmed_abstract>Human ovarian cancer BG-1 cells are a valuable in vitro model that has enabled several laboratories to study the estrogenic responses of ovarian cancers. We recently discovered that there are two different BG-1 cell lines being used for experiments, denoted here as BG-1 FR and BG-1 NIEHS, which exhibit striking morphological differences. The objective of this study was to methodically analyze these two BG-1 variants and compare their characteristics. Short tandem repeat analysis revealed that the DNA profile of BG-1 FR cells was unique, yet the Short tandem repeat pattern of BG-1 NIEHS was identical with that of MCF-7 cells. From a cytogenetic analysis, it became apparent that the BG-1 FR line had the same profile as previously reported, whereas the BG-1 NIEHS and MCF-7 cells share a similar genetic display. A significant number of unique chromosomal translocations were observed between the BG-1 NIEHS and MCF-7 cells, suggesting that acquired genotypic differences resulted in the formation of two lines from a common origin. Although all cell types demonstrated a similar estrogen responsiveness in reporter gene assays, a microarray analysis revealed distinct estrogen-responsive gene expression patterns with surprisingly moderate to low overlap. We conclude that BG-1 FR is the original ovarian cancer cell line, whereas the BG-1 NIEHS is a variant from the MCF-7 cells. These findings provide much needed clarification of the identities and characteristics of key cell line models that are widely used to study estrogen action in female reproductive cancers.</pubmed_abstract><journal>Molecular endocrinology (Baltimore, Md.)</journal><pubmed_title>Research Resource: STR DNA profile and gene expression comparisons of human BG-1 cells and a BG-1/MCF-7 clonal variant.</pubmed_title><pmcid>PMC4250366</pmcid><funding_grant_id>Z01 ES070065</funding_grant_id><pubmed_authors>Hall JM</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Cavailles V</pubmed_authors><pubmed_authors>Liu L</pubmed_authors><pubmed_authors>Gerrish K</pubmed_authors><pubmed_authors>Arao Y</pubmed_authors><pubmed_authors>Burkett S</pubmed_authors><pubmed_authors>Korach KS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Research Resource: STR DNA profile and gene expression comparisons of human BG-1 cells and a BG-1/MCF-7 clonal variant.</name><description>Human ovarian cancer BG-1 cells are a valuable in vitro model that has enabled several laboratories to study the estrogenic responses of ovarian cancers. We recently discovered that there are two different BG-1 cell lines being used for experiments, denoted here as BG-1 FR and BG-1 NIEHS, which exhibit striking morphological differences. The objective of this study was to methodically analyze these two BG-1 variants and compare their characteristics. Short tandem repeat analysis revealed that the DNA profile of BG-1 FR cells was unique, yet the Short tandem repeat pattern of BG-1 NIEHS was identical with that of MCF-7 cells. From a cytogenetic analysis, it became apparent that the BG-1 FR line had the same profile as previously reported, whereas the BG-1 NIEHS and MCF-7 cells share a similar genetic display. A significant number of unique chromosomal translocations were observed between the BG-1 NIEHS and MCF-7 cells, suggesting that acquired genotypic differences resulted in the formation of two lines from a common origin. Although all cell types demonstrated a similar estrogen responsiveness in reporter gene assays, a microarray analysis revealed distinct estrogen-responsive gene expression patterns with surprisingly moderate to low overlap. We conclude that BG-1 FR is the original ovarian cancer cell line, whereas the BG-1 NIEHS is a variant from the MCF-7 cells. These findings provide much needed clarification of the identities and characteristics of key cell line models that are widely used to study estrogen action in female reproductive cancers.</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Dec</publication><modification>2026-05-04T23:26:47.436Z</modification><creation>2019-03-27T01:40:38Z</creation></dates><accession>S-EPMC4250366</accession><cross_references><pubmed>25321415</pubmed><doi>10.1210/me.2014-1229</doi></cross_references></HashMap>